Lin Wang

7PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Communication technology and digital media studiesPredictive and prognostic markersCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 09, 2026
Impact of p16 Status on the Efficacy of Pembrolizumab Combined Nimotuzumab in Recurrent/Unresectable/Metastatic Head and Neck Squamous Cell Carcinoma Patients.

Jieying Li, Yueqin Tao, Haoyue Xu

|Dec 10, 2025
Retraction: Poor condyle position after mandibular reconstruction and a classification system for patients with "VSCU" based on computed tomography: a cross-sectional study with retrospective data collection.

Kexin Wang, Zongxuan He, Xiaochen Yang

|Jun 09, 2025
Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population.

Jieying Li, Kai Zhou, Xiaohong Zhan

|Mar 15, 2025
RAC1 promotes the occurrence and development of tongue squamous cell carcinoma by regulating RAC1/PAK1/LIMK1 signaling pathway.

Zongxuan He, Kai Song, Hongyu Han

|Apr 26, 2024
Retraction Note: Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.

Shengyou Ge, Kexin Wang, Yuxiang Meng

|Apr 15, 2024
Poor condyle position after mandibular reconstruction and a classification system for patients with "VSCU" based on computed tomography: a cross-sectional study with retrospective data collection.

Kexin Wang, Zongxuan He, Xiaochen Yang

Pageof 2

Frequent Collaborators

3 joint publications

Wei Shang

2 joint publications

Kai Song

1 joint publications

Zongxuan He

1 joint publications

Hongyu Han